Fiscal Q3 saw 7.8% sales growth, margin expansion, and strong gains in vending and implant programs, driven by pricing and early volume recovery. Cost structure improvements and sales force optimization supported higher profitability, with positive industrial trends expected to continue.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.